Whether starting or maintaining treatment, the Embark App has multiple features that can help patients on ENBREL throughout their treatment experience. As the healthcare industry continues to evolve ...
NEW YORK (Reuters) - Amgen Inc and Wyeth on Monday said their Enbrel arthritis drug will now carry a prominent black box warning on its package insert label in the United States, citing risks of ...
An advisory panel for the Food and Drug Administration concluded Wednesday that Switzerland.-based Novartis AG’s version of Amgen’s arthritis drug Enbrel should be approved, according to Reuters. The ...
Please provide your email address to receive an email when new articles are posted on . In 2026, Stelara will be discounted 66% from its list price for Medicare users, while Enbrel will be discounted ...
WASHINGTON — Colorado is pioneering a new way for states to crack down on prescription drug costs. In a first-in-the-nation move, a state board voted to create a payment limit for a widely prescribed ...
A drugmaker whose product could be the first subjected to a price cap in Colorado is suing to throw out the state board that deemed its medication unaffordable. In February, the Colorado Prescription ...
Amgen’s arthritis blockbuster Enbrel already owns an undesirable spot on the list of 10 drugs eligible for the first round of Medicare pricing negotiations. Now, the company is fighting back against a ...
Originally approved by the FDA in 1998, Amgen’s Enbrel is still sailing along without facing biosimilar competition in the United States. And unless a court rules otherwise, the Southern California ...
Please provide your email address to receive an email when new articles are posted on . The U.S. Supreme Court has denied a petition from Novartis’ Sandoz to review an earlier U.S. appeals court ...
Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. On Monday, May 17 th, the U.S. Supreme Court decided not to take ...
SAN FRANCISCO (MarketWatch) - Amgen Inc. was ordered by regulators to pull a television ad that overstated the effectiveness of its Enbrel psoriasis treatment. In a letter to Amgen AMGN Chief ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback